US Coronary Pressure Monitors Market Overview:
As per MRFR analysis, the US Coronary Pressure Monitors Market Size was estimated at 6.23 (USD Billion) in 2023. The US Coronary Pressure Monitors Market Industry is expected to grow from 6.85(USD Billion) in 2024 to 12.33 (USD Billion) by 2035. The US Coronary Pressure Monitors Market CAGR (growth rate) is expected to be around 5.496% during the forecast period (2025 - 2035).
Key US Coronary Pressure Monitors Market Trends Highlighted
In the US Coronary Pressure Monitors Market, significant market drivers include the increasing prevalence of cardiovascular diseases, which have been a growing concern due to lifestyle factors and an aging population. The demand for real-time monitoring of patients' cardiovascular health has led to technological advancements in coronary pressure monitoring devices, emphasizing their capabilities for remote patient monitoring and telehealth applications. Innovations such as wireless monitors and integration with digital health records are enhancing patient management and accessibility. Opportunities in this market can be captured by focusing on the development of advanced technologies that improve the accuracy and convenience of coronary pressure monitoring.The push from healthcare providers for improved clinical outcomes is driving the adoption of these devices, and there is a clear market opportunity for manufacturers to create user-friendly solutions that cater to both clinical and at-home settings. Trends in recent times highlight a gradual shift towards preventive healthcare, prompting patients and providers to seek better management tools for cardiovascular risks. Regulatory support from agencies like the FDA has streamlined the approval processes for new medical devices, enabling quicker access to innovative solutions. Additionally, there is an increasing emphasis on personalized medicine, pushing manufacturers to tailor their products to meet specific patient needs.Overall, these dynamic trends reflect a market that is adapting to the evolving healthcare landscape in the US, focusing on improving patient outcomes through advanced technology and innovative practices.

Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
US Coronary Pressure Monitors Market Drivers
Increasing Prevalence of Cardiovascular Diseases
The rise in the prevalence of cardiovascular diseases (CVDs) in the United States is a significant driver for the US Coronary Pressure Monitors Market Industry. According to the American Heart Association, nearly 48% of adults in the United States have some form of cardiovascular disease, which accounted for over 697,000 deaths in 2020 alone. This alarming statistic suggests a growing demand for advanced monitoring solutions, such as coronary pressure monitors, to manage and treat CVDs effectively.As healthcare providers increasingly focus on early diagnosis and managing high-risk patients, the usage of these monitors is anticipated to surge. Major organizations like the Centers for Disease Control and Prevention (CDC) are implementing initiatives aimed at improving heart health awareness and promoting better monitoring practices, thereby creating a favorable environment for the growth of the US Coronary Pressure Monitors Market.
Technological Advancements in Medical Devices
Rapid advancements in technology are playing a pivotal role in enhancing the functionalities of coronary pressure monitors, making them more appealing to healthcare professionals. Innovations such as wireless connectivity, real-time data transmission, and integration with electronic health records are enhancing patient monitoring and management capabilities. According to the Food and Drug Administration, there has been a notable increase in the number of medical device approvals, particularly for cardiac devices, which enables healthcare professionals to utilize state-of-the-art technology for better patient outcomes.Furthermore, significant companies in the sector, such as Medtronic and Abbott, are investing heavily in Research and Development (R&D) to develop cutting-edge coronary pressure monitors. This focus on innovation is expected to drive market growth in the US, as healthcare facilities look to utilize the latest technologies in patient care.
Government Initiatives and Funding for Cardiovascular Health
Government initiatives aimed at improving cardiovascular health play a crucial role in driving the growth of the US Coronary Pressure Monitors Market Industry. The U.S. Department of Health and Human Services has implemented various programs and funding strategies to promote cardiovascular health and reduce the burden of CVDs in the country. The National Heart, Lung, and Blood Institute, in particular, has increased its budget allocations for cardiovascular-related research, which aims to foster innovation in monitoring devices.According to the FY2022 budget estimates, the investment in heart disease research was highlighted as a priority, receiving substantial funding for research initiatives and grants. This backing not only enhances the development of new technologies for coronary pressure monitoring but also facilitates widespread adoption across healthcare systems, bolstering overall market growth.
Growing Geriatric Population in the US
The increasing geriatric population in the United States is contributing significantly to the growth of the US Coronary Pressure Monitors Market. By 2030, it is projected that 20% of the US population will be over 65 years old, reflecting an increase of approximately 18 million individuals. The elderly demographic is particularly susceptible to cardiovascular conditions, necessitating effective monitoring solutions. The availability of coronary pressure monitors becomes crucial for this age group to ensure timely intervention and management of their health.Healthcare facilities are responding to this demographic change by investing in advanced monitoring technologies, making significant strides in chronic disease management. Key organizations like the Administration for Community Living are advocating for improved health strategies for older adults, further promoting the need for innovative solutions in the coronary pressure monitoring space.
US Coronary Pressure Monitors Market Segment Insights:
Coronary Pressure Monitors Market Device Insights
The Device segment of the US Coronary Pressure Monitors Market has been experiencing substantial developments, contributing significantly to the overall market dynamics. This segment encompasses various types of devices that are essential for monitoring arterial pressure, which is crucial for diagnosing and treating cardiovascular conditions. The Sphygmomanometer remains a fundamental tool in clinical settings, providing healthcare professionals with reliable manual blood pressure readings and playing a key role in hypertension management. In recent times, advancements in technology have paved the way for the rise of Automated Blood Pressure Monitors, which offer convenience and accuracy for both healthcare providers and patients. These devices have gained popularity in home healthcare settings, enabling patients to monitor their blood pressure independently and reduce hospital visits. Moreover, BP Transducers are vital components in various medical equipment, offering precise pressure measurements critical for many clinical interventions. Their integration into sophisticated monitoring systems highlights their importance in ensuring patient safety during surgical procedures and inpatient care. Additionally, Ambulatory Blood Pressure Monitors have transformed hypertension evaluation by allowing continuous monitoring over a 24-hour period, providing a more comprehensive understanding of a patient's blood pressure patterns throughout the day and night. This technology supports better treatment plans and enhances patient outcomes, demonstrating its significant role in proactive healthcare management. The growth of the device segment is driven by increasing awareness of cardiovascular diseases and the need for effective monitoring solutions. As the aging population in the US rises and the prevalence of chronic conditions increases, the demand for these innovative devices is expected to see further growth, positioning the US Coronary Pressure Monitors Market as a vital area of focus for healthcare innovation and improvement.

Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
Coronary Pressure Monitors Market End User Insights
The End User segment of the US Coronary Pressure Monitors Market plays a crucial role in the overall functioning and growth of the industry. Within this segment, hospitals and clinics are significant users, primarily due to their need for precise monitoring of cardiovascular health in critical care settings. They require advanced monitoring equipment to manage patients with coronary ailments effectively. Home healthcare has also gained traction, driven by an increasing aging population and a shift towards more personalized healthcare solutions that allow patients to manage their conditions in a familiar environment, which significantly reduces hospital visits.Additionally, the "Others" category includes various healthcare facilities and outpatient centers that leverage coronary pressure monitoring for routine evaluations, reflecting the broad application of this technology. This segmentation reflects a diverse usage of coronary pressure monitors across different healthcare settings, highlighting the growing demand for continuous and remote monitoring solutions in the US healthcare landscape. The continuous evolution of technology and increasing healthcare expenditure further suggest that these end users will heavily influence the market dynamics and trends in the coming years.Furthermore, the rise in cardiovascular diseases in the US is a substantial driver, motivating investments in better monitoring solutions across all end user categories.
US Coronary Pressure Monitors Market Key Players and Competitive Insights:
The US Coronary Pressure Monitors Market is characterized by a dynamic competitive landscape, where numerous players vie for market visibility and share by leveraging innovation and technological advancements. This market is critical as it supports healthcare providers in diagnosing and managing coronary arterial conditions, thereby facilitating improved patient outcomes. The competitive insights reveal that companies are investing significantly in research and development to create sophisticated monitoring devices that offer enhanced accuracy and user-friendliness. Collaboration and strategic partnerships are common strategies employed by these firms to expand their market reach and enhance product offerings, ensuring they stay ahead in a rapidly evolving industry.Omron Healthcare holds a robust position within the US Coronary Pressure Monitors Market, focusing its efforts on delivering high-quality monitoring solutions. The company is recognized for its commitment to innovation and has established a strong reputation for producing reliable and easy-to-use devices tailored for both clinical and home use. One of the key strengths of Omron Healthcare lies in its extensive distribution network, which ensures that its products are readily available to healthcare professionals and patients alike across the United States. The brand is synonymous with reliability in blood pressure monitoring, and its emphasis on consumer education around cardiovascular health helps solidify its standing in a competitive market. Furthermore, Omron's dedication to enhancing user experience through advanced technology and seamless integration with digital health platforms illustrates its proactive approach to meet the evolving needs of healthcare providers and patients.C.R. Bard, on the other hand, also plays a significant role in the US Coronary Pressure Monitors Market, providing a range of products and services aimed at improving cardiovascular health management. The company is well-positioned in this space with its innovative offerings, which include specialized pressure monitoring devices designed for both in-hospital and outpatient settings. C.R. Bard is known for its emphasis on clinical excellence, regularly engaging in strategic mergers and acquisitions to enhance its product portfolio and expand its market reach. These strategic moves have often allowed the company to incorporate cutting-edge technology and ultimately strengthen its position in the industry. With a commitment to extensive research and development, C.R. Bard continues to focus on delivering quality solutions and maintaining comprehensive support systems that appeal to healthcare providers in the US, thus ensuring competitive advantage.
Key Companies in the US Coronary Pressure Monitors Market Include:
Omron Healthcare
C.R. Bard
Smiths Medical
Terumo Corporation
Medtronic
Abbott Laboratories
Boston Scientific
Cardinal Health
B. Braun Melsungen
Philips
Siemens Healthineers
GE Healthcare
Nihon Kohden
Johnson and Johnson
Intuitive Surgical
US Coronary Pressure Monitors Market Industry Developments
In the US Coronary Pressure Monitors Market, notable developments have emerged, particularly in the realm of innovation and mergers. Omron Healthcare and Medtronic have recently unveiled advanced pressure monitoring devices aimed at enhancing cardiovascular diagnostics, emphasizing their commitment to Research and Development. March 2023 saw Smiths Medical expanding its product line, leading to increased market valuation and competitive positioning. Meanwhile, Abbott Laboratories announced intentions to acquire C.R. Bard in February 2023, which aligns with broader market trends of consolidation among major players. Also reported, Philips has introduced a new telemetry system for seamless cardiac monitoring, further solidifying its presence in the market. Over the last two years, the rise in chronic cardiovascular diseases in the US prompted companies like GE Healthcare and Boston Scientific to ramp up their production capacities to meet escalating demand. FDA approvals for next-generation monitors from companies such as Nihon Kohden in January 2022 have also triggered investments towards enhancing operational efficiencies. Collectively, these factors underscore an optimistic growth trajectory for the US Coronary Pressure Monitors Market, driven by technological advancements and strategic acquisitions among key industry participants.
US Coronary Pressure Monitors Market Segmentation Insights
Coronary Pressure Monitors Market Device Outlook
Sphygmomanometer
Automated Blood Pressure Monitor
BP Transducers
Ambulatory Blood Pressure Monitor
Coronary Pressure Monitors Market End User Outlook
Hospitals & Clinics
Home Healthcare
Others
Report Scope:
Report Attribute/Metric Source: |
Details |
MARKET SIZE 2018 |
6.23(USD Billion) |
MARKET SIZE 2024 |
6.85(USD Billion) |
MARKET SIZE 2035 |
12.33(USD Billion) |
COMPOUND ANNUAL GROWTH RATE (CAGR) |
5.496% (2025 - 2035) |
REPORT COVERAGE |
Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
BASE YEAR |
2024 |
MARKET FORECAST PERIOD |
2025 - 2035 |
HISTORICAL DATA |
2019 - 2024 |
MARKET FORECAST UNITS |
USD Billion |
KEY COMPANIES PROFILED |
Omron Healthcare, C.R. Bard, Smiths Medical, Terumo Corporation, Medtronic, Abbott Laboratories, Boston Scientific, Cardinal Health, B. Braun Melsungen, Philips, Siemens Healthineers, GE Healthcare, Nihon Kohden, Johnson and Johnson, Intuitive Surgical |
SEGMENTS COVERED |
Device, End User |
KEY MARKET OPPORTUNITIES |
Increasing prevalence of cardiovascular diseases, Technological advancements in monitoring devices, Growing geriatric population requiring monitoring, Rising demand for non-invasive procedures, Expanding healthcare infrastructure and investment |
KEY MARKET DYNAMICS |
Rising cardiovascular disease prevalence, Technological advancements in monitoring, Increasing demand for minimally invasive procedures, Growing geriatric population, Favorable reimbursement policies |
COUNTRIES COVERED |
US |
Frequently Asked Questions (FAQ) :
The US Coronary Pressure Monitors Market is expected to be valued at 6.85 billion USD in 2024.
By 2035, the market is projected to reach a value of 12.33 billion USD.
The expected CAGR for the US Coronary Pressure Monitors Market during this period is 5.496 percent.
The Automated Blood Pressure Monitor segment is anticipated to have a significant share, valued at 2.1 billion USD in 2024.
The Sphygmomanometer segment is expected to be valued at 3.45 billion USD by 2035.
Key players include Omron Healthcare, C.R. Bard, Smiths Medical, and Medtronic among others.
The BP Transducers segment is projected to be valued at 1.5 billion USD in 2024.
Ambulatory Blood Pressure Monitors are expected to show significant growth, valued at 1.3 billion USD in 2024.
The BP Transducers segment is expected to reach a value of 2.8 billion USD by 2035.
The stable growth rate and increasing market value present promising investment opportunities in the cardiovascular health sector.